Symptom Scores May Signal Neuropathy Risk - Summary - MDSpire
From the Journals

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.

  • By

  • Andrea Surnit

  • May 6, 2026

  • 4 min

Share

Research from The University of Texas MD Anderson Cancer Center highlights the potential of patient-reported symptom scores in identifying oropharyngeal cancer survivors at risk for delayed hypoglossal nerve neuropathy. The study, which reviewed data from 1,297 treated patients from 2015 to 2023, developed the MDASI-HN-NERVE score to reflect bulbar-related symptom burden. A significant correlation was found between higher symptom scores and the risk of neuropathy, suggesting symptom-based surveillance could be essential for risk stratification in survivors.

Original Source(s)

Symptom Scores May Signal Neuropathy Risk

  • by Andrea Surnit

  • May 6, 2026

Related Content

Reduced-Dose Radiation Shows Durable Control

Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation

Ergonomic Risk in Head and Neck Surgery

Study suggests intraoperative pain and risk rise with case complexity and duration.